Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2022 | Story Rulanzen Martin | Photo Supplied
Dr Sello Thinane
Dr Jonas Thinane graduated with a PhD from the University of South Africa.

Dr Jonas Thinane, who recently obtained his PhD in Theology from the University of South Africa (Unisa), has been working in the Department of Hebrew since his first year as a Theology student; he is currently employed as departmental administrator in the department. 

It was his diligence and comments that convinced Prof Cynthia Miller-Naude to offer him employment as student assistant in the department.  His work involves overseeing the administration of three entwined units within the department.  “I am really proud of all that he has accomplished since then, seizing every opportunity available for learning and growing, without allowing obstacles to block his path,” said Prof Miller-Naude. 

His PhD focused on Human rights abuse by some self-styled spiritual leaders within the ‘Nyaope religion’ in South Africa and was supervised by Prof MS Kgatle from the Department of Christian Spirituality, Church History and Missiology at Unisa. 

An avid academic and researcher 

Apart from the research he undertook to complete his PhD in less than two years, he published nine accredited articles and a chapter in a book between 2021 and 2022. “I currently have six articles undergoing peer review and am working on more to publish in local and international journals this year,” says Dr Thinane. 

Dr Thinane’s research specialisation lies within Missiology, where he has introduced new knowledge to the subject matter through extensive writing on concepts of missio hominum (mission of human beings) in relation to the broader setting of the Missio Dei (Mission of God). “Beyond this, some of my published articles cover broad yet relevant topics such as COVID-19 and vaccine challenges in South Africa, the question of mandatory vaccination from a religious perspective, the ANC step-aside rule in conflict with Thuma Mina objectives, and many other topics relevant to our current challenges in South Africa,” Dr Thinane says. 

“I am sure that he will make a great contribution to academia for the benefit of society in the future,” says Prof Miller-Naude. 

Support and motivation from department 

Dr Thinane is very appreciative of the support he received from the department throughout his PhD journey. 
This is indeed a great achievement within the scope of the UFS’ encouragement for publication on subjects that greatly contribute to the cognition and advancement of our society.
Dr Thinane graduation
From the left: Dr KJ Padi (UFS Practical and Missional Theology), Dr A Motsei (UFS African Languages), Dr JS Thinane (Department of Hebrew),
Dr M Choane (UFS Political Studies and Governance), Prof MS Kgatle (UNISA Department of Christian Spirituality, Church History and Missiology),
Dr ME Maibi (UFS alumnus). (Photo: Supplied)

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept